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Abstract
Purpose of Review This systematic review describes evidence concerning medicinal plants that, in addition to exerting hypo-
glycemic effects, decrease accompanying complications such as nephropathy, neuropathy, retinopathy, hypertension, and/or
hyperlipidemia among individuals with diabetes mellitus (DM).
Recent Findings Studies on the antidiabetic mechanisms of medicinal plants have shown that most of them produce hypogly-
cemic activity by stimulating insulin secretion, augmenting peroxisome proliferator-activated receptors (PPARs), inhibiting α-
amylase or α-glucosidase, glucagon-like peptide-1 (GLP-1) secretion, advanced glycation end product (AGE) formation, free
radical scavenging plus antioxidant activity (against reactive oxygen or nitrogen species (ROS/RNS)), up-regulating or elevating
translocation of glucose transporter type 4 (GLUT-4), and preventing development of insulin resistance.
Summary Not only are medicinal plants effective in DM, but many of them also possess a variety of effects on other disease states,
including the complications of DM. Such plants may be appropriate alternatives or adjuncts to available antidiabetic medications.
Keywords Diabetesmellitus . Medicinal plants . Nephropathy . Neuropathy
Introduction
Diabetes mellitus (DM) is one of the most common endocrine
diseases worldwide, and the number of people with DM was
recorded as 422 million in 2014 [1]. Type 1 DM is caused by
impaired insulin secretion, while type 2 DM is related to pro-
gressive insulin resistance in the liver and peripheral tissues,
as well as relative insulin deficiency [2].
DM along with impaired glucose tolerance is a life-
threatening illness that increases the risk of cardiovascular
disease by as much as eight times [3]. The disease accounts
for 60% of non-invasive amputations in the USA [3], and in
2015, 30.3 million Americans were regarded to have DM, 7.2
million of which were thought to be undiagnosed [4]. In the
same year, an estimated 1.6 million deaths were directly at-
tributed to DM and a further 2.2 million deaths were ascribed
to high blood glucose [5]. It was also estimated that, by the
year 2040, the number of adults with DM would increase to
642 million globally [6]. Higher-than-optimal blood glucose
caused deaths, by increasing the risks of cardiovascular and
other diseases. Forty-three percent of these deaths occurred
before the age of 70 years [1].
Hyperglycemia causes an increase in oxidative stress,
resulting in inflammation, activation of the polyol pathway,
and damage to various organs of the body [7, 8]. DM requires
diagnosis accompanied by medical management with lifestyle
modification although currently, no successful causal treatment
has been discovered. There are many synthetic drugs for the
symptomatic treatment of DM, but none of them are able to
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definitively alleviate the disease origin [9]. Common symptom-
atic treatments include regular injection of insulin or oral
administration of antidiabetic drugs, such as sulfonyl-
ureas, α-glucosidase inhibitors, biguanides, thiazolidinediones,
dipeptidyl peptidase-4 (DPP4) inhibitors, sodium-glucose
co-transporter-2 (SGLT2) inhibitors, glinides, and paren-
teral administration of glucagon-like peptide-1 (GLP-1)
agonists, which can cause moderate to severe side effects
[10]. As a result, alternative treatments are urgently needed
for more effective management of the disease.
Complementary and alternative medicine (CAM) is in-
creasingly being used as a DM management strategy. In this
context, traditional herbal medicine is used across the world
for disease treatment [11]. TheWorld Health Organization has
recommended that clinicians use herbal drugs to treat DM in
addition to its complications. There is no ultimate method
available to prevent and treat DM, but strategies are needed
to reduce the complications brought about by the disease [12,
13]. Some medicinal plants with antioxidant properties are
useful for reducing oxidative stress and its adverse effects
[14, 15], and nowadays, some of the available drugs are plant
based [16]. Research has shown that a number of antidiabetic
plants, apart from their hypoglycemic activity, have other use-
ful properties such as antihypertensive, nephroprotective and
retinoprotective activities which may be useful against
the most common complications of DM. Thus, con-
sumption of these plants may well be exploited in the
control of DM and its complications [17, 18]. Hence,
the purpose of this article is to systematically review the me-
dicinal plants that are useful in the management of DM and its
accompanying complications.
Materials and Methods
To conduct this review, firstly the complications caused by
DM were addressed. Subsequently, underlying antidiabetic
mechanisms of medicinal plants were reviewed under general
thematic headings. For this purpose, the articles indexed in
PubMed, Scopus, Web of Science, MEDLINE, Google
Scholar, Web of Science (SCOPUS), EBSCO Academic
Search, Cochrane Central Register of Controlled Trials
(CENTRAL), and the Chinese Network Knowledge
Infrastructure (CNKI), published prior to 2018, and retrieved
using the keywords “hypertension,” “retinopathy,” “neuropa-
thy,” and “nephropathy” or “medical plants for diabetic hy-
pertension or retinopathy or nephropathy or neuropathy”were
reviewed. Articles containing plants affecting one or more of
the above items were selected.
A total of 36,000 publications were retrieved by the first
selection process. Out of these publications, 305 articles iden-
tified in medical plants were examined against DM and/or
diabetic complications (hypertension, retinopathy,
nephropathy, neuropathy, and/or hyperlipidemia). After a
more detailed review of these articles, 89 relevant papers were
selected and their applicable findings summarized in tabular
form.
Results
Medicinal Herbs Effective on Diabetes
The use of antioxidants and the reduction and control of blood
glucose significantly reduce the complications associated with
DM [12, 13]. Consequently, medicinal plants with antioxidant
properties are employed to restrict oxidative stress and its
adverse effects [14, 19]. A number of medicinal plants with
antidiabetic and antihyperlipidemic effects are known to be
effective in preventing and treating DM.
Antidiabetic Plant Mechanisms
There are several fundamental modes of action for natural
products in DM [20]. The principal mechanisms include those
that act by stimulating insulin secretion, augmenting peroxi-
some proliferator-activated receptors (PPARs), inhibiting α-
amylase or α-glucosidase, inhibiting the secretion of the
incretin, GLP-1, inhibiting advanced glycation end-product
(AGE) formation, free radical scavenging plus antioxidant
activity (against reactive oxygen or nitrogen species (ROS/
RNS)), up-regulating or elevating translocation of glucose
transporter type 4 (GLUT-4), and preventing development of
insulin resistance (Fig. 1).
Fig. 1 Diagram depicting some of the principle plant-derived
mechanisms of antidiabetic activity. GLUT-4, insulin-regulated glucose
transporter type 4; ROS, reactive oxygen species; RNS, reactive nitrogen
species; AGE, advanced glycation end products; DPP4, dipeptidyl
peptidase; GLP-1, glucagon-like peptide-1 (incretin); PPARs,
peroxisome proliferator-activated receptors
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Insulin Secretagogues
Some plants or their constituents stimulate insulin secretion.
They include Panax ginseng [21] and the diosgenin compo-
nent in Fenugreek (Trigonella foenum graecum) [22–24]
which also increases glucose metabolism not only by stimu-
lating adipocyte differentiation but also via a reduction of
inflammation in adipocytes [25]. There is in addition, an in-
sulin secretagogic action of the compound S-methyl cysteine
sulfoxide which has been isolated from the onion plant
(Allium cepa) [26].
Increased Expression of Peroxisome Proliferator-Activated
Receptors
In bitter melon (Momordica charantia L.), 9cis,11trans,13-
trans-conjugated linolenic has been found to activate
PPAR-α in rat tissues [27]. In addition, momordin extracted
from bitter melon, increases the expression of human PPAR-δ
mRNA and the production and activation of PPAR-δ is further
upregulated through PPAR-δ promoter activity [28].
α-Amylase and α-Glucosidase Inhibition
Azadirachtolide, isolated from Azadirachta indica (also
known as Neem tree) has been shown to exhibit anti-
hyperglycemic and anti-lipidemic actions in diabetic rats.
Furthermore, an inhibitory activity of azadirachtolide on α-
amylase and α-glucosidase has been demonstrated, suggest-
ing that this A. indica constituent is potentially beneficial in
the management of DM associated with an abnormal lipid
profile coupled with related cardiovascular complications
[29]. Moreover, the limonoids azadiradione and gedunin plus
the tetranortriterpenoid compound meliacinolin isolated
from A. indica, are also inhibitory on both α-amylase
and α-glucosidase further indicating that this medicinal
plant has a propensity to reduce post-prandial hypergly-
cemia in the diabetic condition [30, 31]. Additionally,
extracts from cinnamon bark species possess inhibitory
activity against intestinal α-glucosidase and pancreatic
α-amylase [32] and even after chronic extract adminis-
tration, α-glucosidase activity remains at a low level, so
this natural product has promise in DM [33]. What is
more, an extract of onion (A. cepa) containing the phe-
nolic compound quercetin, also possesses α-glucosidase
inhibitory activity [34].
Increased Glucagon-Like Peptide-1 Secretion
It has been demonstrated in vitro and in vivo that the
saponin ginsenosides present in P. ginseng stimulate
GLP-1 secretion, and this incretin reduces hyperglyce-
mia significantly contributing toward an antidiabetic
effect [35]. Apart from P. ginseng, other medicinal plants in-
cluding Anemarrhena asphodeloides, Citrus aurantium,
Bupleurum falcatum, and Gentiana scabra also have GLP-1
secretogogic activity [36].
Inhibition of Advanced Glycation End-Product Formation
AGEs cause inflammation and have a crucial role in generat-
ing diabetic complications. In light of this, catalpol isolated
from Rehmannia glutinosa restrains AGE-mediated inflam-
mation by inhibiting ROS production and NADPH-oxidase
activity, and this is considered to prevent AGE-mediated prob-
lems in DM [37]. An extract from A. indica also inhibits AGE
formation in addition to oxidative stress, and it is thought to
have a protective effect in diabetic kidney disease [38].
Similarly, a Piper auritum leaf extract has been reported to
have concomitant antioxidant as well as AGE inhibitory
activities [39].
Free Radical Scavenging Activity
An extract from R. glutinosa rhizome displayed free radical
scavenging activity reducing the level of ROS intracellularly
in addition to diminishing pro-inflammatory gene expression,
and this finding has been advocated as a therapeutic possibil-
ity for DM [40]. Likewise, T. foenum graecum (Fenugreek)
seeds boost antioxidant status in the blood suggesting that
perturbed free radical metabolism in the diabetic condition
may be returned to normal [41]. It is of note in this regard that
a range of other plants used to treat DM, exhibit activity in the
2,2-diphenyl-1-picrylhydrazyl (DPPH) test for free radical
scavengers [39].
Reduction of Antioxidant/ROS/RNS Activity
Invariably, studies on free radical scavengers are performed in
the context of antioxidant activity. Thus, R. glutinosa has
strong free radical scavenging effects which are coincident
with a reduced production of ROS [40], and this is attributable
to catalpol [37]. Fenugreek increases lipid peroxidation and
blood antioxidants in diabetic rats [41], and its constituent
trigonelline acts by affecting ROS [22] while the steroidal
saponin, diosgenin, also present in yam (Dioscoreaceae fam-
ily), modulates oxidative stress [42]. The ginsenoside-Rg1
component of P. ginseng improves angiogenesis in diabetic
ischemic rat hindlimb which is believed to be through in-
creased activation of endothelial nitric oxide synthase
(eNOS) [43]. Another P. ginseng constituent, 20(S)-
ginsenoside Rg(3), produces positive effects on diabetic renal
damage which have been assigned to inhibition of NMDA
receptor-mediated nitrosative stress [44]. It is also noteworthy
that there are other examples of antidiabetic plant-induced
antioxidant activity [39].
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Table 1 Medicinal plants with multiple functions in diabetes mellitus
Scientific name Family Hyperglycemia Nephropathy Neuropathy Retinopathy Hypertension Hyperlipidemia Reference
Anacardium occidentale
(leaf)
Anacardiaceae ☑ ☑ [58]
Achillea milefolium (leaf) Asteraceae ☑ ☑ ☑ [59, 60]
Althea officinalis (root) Malvaceae ☑ ☑ [61]
Allium iranicom (leaf,
bulb)
Liliaceae ☑ ☑ [62••]
Allium cepa (leaf, bulb) Liliaceae ☑ ☑ ☑ [63, 64]
Allium sativum (leaf, bulb) Liliaceae ☑ ☑ ☑ ☑ [65, 66]
Aloe vera (leaf) Liliaceae ☑ ☑ ☑ [67–72]
Anethum graveolens
(leaf, seed)
Apiaceae ☑ ☑ ☑ [73, 74]
Angelica sinensis Umbelliferae ☑ [75]
Annona squamosa (leaf) Annonaceae ☑ ☑ ☑ [57, 76]
Annona muricata (leaf) Annonaceae ☑ ☑ ☑ ☑ [58]
Astragalus membranaceus Fabaceae ☑ ☑ [59–82]
Apium graveolens (leaf) Umbellifera ☑ ☑ ☑ [83, 84]
Artemisia vulgaris (leaf) Compositae ☑ ☑ [85]
Arctium loppa (root) Compositae ☑ ☑ ☑ [62••]
Avena sativa (fruit) Germinaceae ☑ ☑ ☑ [86]
Berberris vulgaria
(root/fruit)
Berberidaceae ☑ ☑ ☑ [87, 88]
Boerhaavia diffusa (leaf) Nyctaginaceae ☑ [89, 90]
Boswellio carteri (resin) Burceraceae ☑ ☑ [91]
Bougainvillea spectabilis
(leaf)
Nyctaginaceae ☑ [92]
Bridelia ndellensis (leaf) Euphorbiaceae ☑ [93]
Camellia sinensis Green tea ☑ ☑ [94–98]
Canavalia ensiformis
(seeds)
Leguminosae ☑ ☑ ☑ ☑ [99, 100]
Casearia esculenta Flacourtiaceae ☑ ☑ [101–103]
Cassia kleinii (leaf) Caesalpiniaceae ☑ [104]
Castanospermum austral
(seeds)
Fabaceae ☑ ☑ [105]
Capsicum frutescens Solanaceae ☑ [106–110]
Catharanthus roseus (leaf) Apocyaceae ☑ [111]
Chicorium intybus (root) Compositae ☑ ☑ ☑ [112]
Citrus limon (fruit) Rutaceae ☑ ☑ ☑ [113]
Cinnamomum verum
(bark)
Lauraceae ☑ ☑ ☑ [114]
Cinnamonum cassia Lauraceae ☑ [115]
Cinnamomum
zeylanicum
Lauraceae ☑ [116]
Citrus aurantium (fruit) Rutaceae ☑ ☑ ☑ [117, 118]
Citrus paradise (fruit) Rutaceae ☑ ☑ ☑ [119, 120]
Coccinia indica (fruit) Cucurbitaceae ☑ [121]
Colocassia esculenta Araceae ☑ [122]
Cocculus hirsutus (leaf) Menispermaceae ☑ ☑ [123]
Coscinium fenestratum
(stem)
Menispermaceae ☑ [124]
Coriandrum sativom
(fruit)
Umbelliferae ☑ ☑ [62••]
Cornus mas (fruit) Cornaceae ☑ ☑ ☑ [125, 126]
Crataegus microphylla
(leaf/fruit)
Rosaceae ☑ ☑ ☑ [127]
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Table 1 (continued)
Scientific name Family Hyperglycemia Nephropathy Neuropathy Retinopathy Hypertension Hyperlipidemia Reference
Cryptomeria japonica
(leaf)
Cupressaceae ☑ ☑ [128]
Cucumis melo (fruit) Cucurbitaceae ☑ ☑ ☑ [129, 130]
Curcubita pepo (fruit) Curcubitaceae ☑ ☑ ☑ [131]
Cynara cardunculus
(flower)
Asteraceae ☑ ☑ [132]
Curcuma longa Zingiberaceae ☑ ☑ [133, 134]
Daucus carota (fruit) Umbelliferae ☑ ☑ [135]
Descurainia sophia (seeds) Brassiacaceae ☑ ☑ [136]
Desmodium styracifolium
(flower)
Fabaceae ☑ ☑ [137]
Dioscorea dumetorum
(stem)
Dioscoreaceae ☑ ☑ [138, 139]
Dioscorea cayenensis Dioscoreaceae ☑ [122]
Ficus hispida (bark) Moraceae ☑ [140, 141]
Fish oil ☑ ☑ [142–144]
Ganoderma lucidum Ganodermataceae ☑ [145]
Ginkgo biloba Ginkgoaceae ☑ ☑ ☑ [146–149]
Gymnema montanum Asclepiadaceae ☑ [150]
Glycine max ☑ ☑ [151]
Hypoxis hemerocallidea
Fisch. Mey.
Hypoxidaceae ☑ [152, 153]
Juglans regia Juglandaceae [154]
Linum usitatissimum Linaceae ☑ ☑ [155, 156]
Lycium barbarum Solanacaea ☑ [157]
Momordica charantia Cucurbitacaea ☑ ☑ [158]
Murraya koenigii Linn. Rutaceae ☑ [159]
Oenothera biennis Onagraceae ☑ [160]
Olea europaea Oleaceae ☑ [161, 162]
Paeonia suffruticosa Paeoniaceae ☑ [163]
Panax ginseng (root) Araliaceae ☑ ☑ [164]
Panax notoginseng Araliaceae ☑ [165, 166]
Pinus pinaster Pinaceae ☑ [167, 168]
Polygonatum odoratum Asparagaceae ☑ [169]
Propolis ☑ [170, 171]
Pueraria lobata Fabaceae [172, 173]
Punica granatum Lythraceae ☑ [174]
Rehmannia glutinosa Orobanchaceae [175, 176]
Rheum officinale Polygonaceae ☑ [177]
Rhodiola rosea Crassulaceae [115]
Salvia hispanica Lamiaceae ☑ [178]
Salvia miltiorrhiza Lamiaceae ☑ ☑ [179–181]
Silybum marianum Asteraceae ☑ [182]
Syzyguim cumini
(leaf/fruit/seeds/
bark/tea)
Myrtaceae ☑ ☑ ☑ [183–185]
Terminalia chebula
(seeds)
Combretaceae ☑ ☑ [186]
Terminalia catappa (fruit) Combretaceae ☑ ☑ ☑ [187]
Tinospora cordifolia Menispermaceae ☑ [188]
Trigonella foenum
graecum
Fabaceae ☑ [189, 190]
Curr Diab Rep  (2018) 18:72 Page 5 of 13  72 
Table 1 (continued)
Scientific name Family Hyperglycemia Nephropathy Neuropathy Retinopathy Hypertension Hyperlipidemia Reference
Vaccinium myrtillus Ericaceae ☑ [191]
Vitis vinifera Vitaceae ☑ ☑ ☑ ☑ [182, 187,
192]
Withania somnifera Solanaceae [193, 194]
Zingiber officinal Zingiberaceae ☑ [165, 195]
Table 2 Mechanism actions of medicinal plants on diabetes and its complications
Scientific name Family Mechanism Reference
Anacardium occidentale Linn. Anacardiaceae The antihyperglycemic and nephroprotective effects are related to reducing
diabetes-induced functional and histological alterations in the kidneys and
reduced accumulation of mucopolysaccharides in the kidneys.
[165]
Annona squamosa Linn. Annonaceae The antidiabetic and hypoglycemic effects of this plant are associated with increased
insulin levels in the pancreatic islets, increased glucose consumption in the
muscles, and inhibition of hepatic glucose uptake.
[76]
Annona muricata Linn. Annonaceae Reduction of oxidative stress on pancreatic Β cells. The treatment increased the area
of insulin immunoreactive Β cells and partially prevented degeneration of B cells
[78]
Boerhaavia diffusa Linn. Nyctaginaceae The antidiabetic effects of this plant are caused by lowering blood glucose levels and
increasing insulin sensitivity.
[89]
Bougainvillea spectabilis Linn. Nyctaginaceae The antihyperglycemic effects induced by this plant are due to the increased
conversion of glucose to glycogen in the kidney and increased insulin sensitivity.
[92]
Bridelia ndellensis Beille. Euphorbiaceae Antidiabetic effects of this plant cells and requires functional B-cell islets [196]
Canavalia ensiformis DC. Leguminosae The antihyperglycemic and antihyperlipidemic effects of this plant are due to its
decreasing blood glucose and urine levels, as well as its decreasing triglyceride,
ketone bodies, and cholesterol associated with diabetes mellitus.
[197]
Casearia esculenta Roxb. Flacourtiaceae The hypoglycemic effects induced by this plant are associated with reduced blood
glucose levels and affecting the metabolism of proteins and marker enzymes.
[103]
Cassia kleiniiWight & Arn. Caesalpiniaceae Reducing blood glucose levels [104]
Catharanthus roseus Linn. Apocyaceae The mechanism of hypoglycemic action of this plant is associated with prophylactic
activity against necrotic actions.
[198]
Affecting carbohydrate metabolism enzymes.
Increasing insulin secretion.
Helping prevent damage due to free radical oxygen and exerting antioxidant effects.
Increasing glucose uptake in tissues
Coccinia indica Wight & Arn. Cucurbitaceae Exerting B ell restorative properties against alloxan induced damage [199]
Cocculus hirsutus Linn. Menispermaceae Exerting antihyperglycemic effects by reducing serum glucose levels and increasing
glucose resistance.
[123]
Coscinium fenestratum Colebr. Menispermaceae Regulating the metabolism and improving the antioxidant effects. Regulating the
glucose homeostasis and reducing gluconeogenesis. Exerting supportive effect on
the antioxidant defense of the cell.
[124]
Dioscorea dumetorum Pax. Dioscoreaceae Exerting antihyperlipidemic effects in the body by controlling hyperketonemia and
hypercholesterolemia.
[139]
Ficus hispida Linn. Moraceae Reducing fasting blood glucose levels by directly influencing beta cells [141]
Hypoxis hemerocallidea Fisch.
Mey.
Hypoxidaceae The mechanism of the hypoglycemic effect of this plant has not yet been determined
yet.
[153]
Murraya koenigii Linn. Rutaceae Exerting hypoglycemic effects by increasing liver glycogen concentration and
affecting carbohydrates metabolism
[200]
Panax ginseng Linn. Araliaceae Exerting hypoglycemic effects by affecting the metabolism of carbohydrates. [165]
Syzyguim cumini Linn. Myrtaceae Hypoglycemic effects can be exerted via different mechanisms only in disease
conditions and in diabetic people.
[185]
Terminalia chebula Retz Combretaceae This plant has renoprotective action. [186]
Terminalia catappa Linn. Combretaceae Exerting antidiabetic and antihyperglycemic effects through regeneration of beta
cells due to B-carotene in reducing diabetic complications like glycosylation
[187]
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Increased, Up-regulation, and Translocation of Glucose
Transporter Type 4
Glut-4 is one of the most important insulin-regulated glucose
transporters located at the surface membrane of adipocytes,
skeletal and cardiac muscle cells. A triterpenoid constituent of
M. charantia fruit, cucurbitane [45], stimulates GLUT-4 cell
membrane translocation to facilitate glucose uptake and
AMP-activated protein kinase (AMPK) phosphorylation
[46–48]. A comparable effect occurs with an extract of A. cepa
[49]. Likewise, in mouse adipocytes, an aqueous extract of
Cinnamon evokes a biphasic action on GLUT-4 mRNA [50]
whereas an active constituent of the plant, cinnamaldehyde,
increases glucose uptake through augmented GLUT-4 translo-
cation [51]. Ginsenoside-Rh2 present in P. ginseng decreases
plasma glucose in diabetic rats by increasing GLUT-4 expres-
sion via a more indirect mechanism arising from elevated
β-endorphin stimulation of μ-opioid receptors [52].
Insulin Resistance Reduction
Insulin resistance (IR) is a pathological condition in which
cells do not respond normally to insulin. In this respect,
Ocimum sanctum (Holy basil) delays the onset of IR in rats
and has been proposed as an adjuvant therapy for patients who
develop this condition [53]. Also, in rats, meliacinolin isolated
from the leaves of A. indica inhibits IR among a number of
other antidiabetic modes of action [31]. Analogously, M.
charantia ameliorates IR inmice though the underlyingmech-
anism has been hypothesized to be through PPAR-γ-mediated
pathways [54].
There are over 400 plant species with hypoglycemic prop-
erties. However, the study of new antidiabetic, plant-derived
drugs is still pursued and continues to draw attention because
of potential safety issues. Most of the plants contain alkaloids,
glycosides, terpenoids, flavonoids, and carotenoids, to which
their antidiabetic properties have been attributed. Several me-
dicinal plants such as Galega officinalis, in addition to pro-
ducing positive effects on glucose homeostasis in patients
with DM, have found application in preventing and treating
hypertension, cardiovascular disease, and kidney injury [13,
55, 56•, 57]. In addition to producing hypoglycemic effects,
numerous plants have been demonstrated to be effective
against the wide range of diabetic complications (Table 1).
In Table 2, the mechanisms of the effects of these plants are
summarized.
Conclusion
Problems arising from IR and chronic hyperglycemia have
become a major concern in clinical science and drug therapy.
Medicinal plants have usually attracted attention conceivably
due to fewer side effects than chemically synthetic drugs. The
antihyperglycemic effects of the plants presented in this article
are essentially related to their ability to maintain pancreatic
function and insulin output facilitating anabolic activities such
as muscle, adipocyte, and hepatic glucose uptake as well as
glucose-to-glycogen conversion.
Oxidative stress induced by hyperglycemia plays an
important role in the expansion of the extracellular ma-
trix and glucose-induced collagen production [201].
When endothelial cells respond to increased glucose,
the production of reactive nitrogen species and ROS
increases. The production of these reactive substances
triggers single-strand breakage of DNA, and subsequent-
ly increases the levels of 8-hydroxyguanine and 8-
hydroxydeoxy guanosine (markers of oxidative stress-
induced DNA damage) in plasma and tissues. The con-
centrations of these products can be restrained by con-
trolling hyperglycemia and using antioxidants [202].
Studies have shown that the use of antioxidants has been suc-
cessful in preventing DM-induced disorders, including neu-
ropathy, nephropathy, and retinopathy. High doses of single
antioxidants, such as vitamin E or C, may interfere with
the antioxidant-provident balance in the cellular system,
so it has been suggested that a mixture of therapeutic
antioxidants with trace elements and vitamins may be
used to improve the metabolic system [203]. More im-
portantly, single antioxidants may not be able to coun-
teract all free radical species; hence, medicinal plants
which possess a wide range of phytochemicals with an-
tioxidant activities may be more efficient.
Although treatment with medicinal plants has signif-
icant effects on pancreatic β cell-reducing blood glucose
levels as well as other DM-related complications, there
is scant information on their biology, especially on how
they actually affect DM. However, it has been shown
that most medicinal plants contain compounds such as
glycosides, alkaloids, terpenoids, and flavonoids, which
mitigate DM by exerting antioxidant effects and other
related activities [68–70]. Taken together, although
plants may have antidiabetic effects with their own spe-
cific action mechanism, almost all of them display anti-
oxidant properties and a range of other contributory ac-
tions. Given that oxidative stress is one of the main
causes of DM and its related disorders, it is likely that
the antioxidant effect of these plants plays a major role
in their effectiveness.
Finally, it can be concluded that medicinal plants that pro-
duce a profile of concomitant effects may be considered alter-
native or adjunctive drugs for the treatment or prevention of
DM and its complications. It is, however, essential to study the
effects of medicinal plants on DM in more detail in order to
obtain further data on the biology and pharmacological effects
of these plants.
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